• AAPL 169.3
  • TSLA 168.29
  • AMZN 179.62
  • MSFT 406.32
  • INTC 31.88
  • EURUSD 1.0699
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. MU /
  3. 1HM.MU

Adaptive Biotechnologies Corporation (1HM MU) stock market data APIs

€2.379 -0.04(-1.7%) as of April 26, 2024

Adaptive Biotechnologies Corporation Financial Data Overview

2.417
2.379
-
2.417
2.379
2.214-8.086
359 M
145 M
170 M
1.241
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '1HM',
Type: 'Common Stock',
Name: 'Adaptive Biotechnologies Corporation',
Exchange: 'MU',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Adaptive Biotechnologies Corporation Fundamental Data is available in our Financial Data APIs

  • Net Revenue 170 M
  • EBITDA -179 375 008
  • Earnings Per Share -1.46
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Adaptive Biotechnologies Corporation Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get Adaptive Biotechnologies Corporation End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Adaptive Biotechnologies Corporation latest news via APIs

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024

Adaptive Biotechnologies SEATTLE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics o...

Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Adaptive Biotechnologies SEATTLE, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics o...
Do you have any questions?
support@eodhistoricaldata.com